11 C-PBR28 and 18 F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
The objective of this study was to assess microglial activation in lesions and in normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients using PET. Thirty-four MS patients (7 with secondary progressive MS [SPMS], 27 with relapsing remitting MS [RRMS]) and 30 healthy volunteers, gen...
Gespeichert in:
Veröffentlicht in: | Journal of Nuclear Medicine 2017-09, Vol.58 (9), p.1477-1482 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1482 |
---|---|
container_issue | 9 |
container_start_page | 1477 |
container_title | Journal of Nuclear Medicine |
container_volume | 58 |
creator | Datta, Gourab Colasanti, Alessandro Kalk, Nicola Owen, David Scott, Gregory Rabiner, Eugenii A Gunn, Roger N Lingford-Hughes, Anne Malik, Omar Ciccarelli, Olga Nicholas, Richard Nei, Lei Battaglini, Marco De Stefano, Nicola Matthews, Paul M |
description | The objective of this study was to assess microglial activation in lesions and in normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients using PET.
Thirty-four MS patients (7 with secondary progressive MS [SPMS], 27 with relapsing remitting MS [RRMS]) and 30 healthy volunteers, genetically stratified for translocator protein (TSPO) binding status, underwent PET scanning with TSPO radioligands (
C-PBR28 or
F-PBR111). Regional TSPO availability was measured as a distribution volume ratio (DVR) relative to the caudate (a pseudoreference region). White matter lesions (WMLs) were classified as "active" (DVR highest in the lesion), "peripherally active" (perilesional DVR highest), "inactive" (DVR highest in surrounding NAWM), or "undifferentiated" (similar DVR across lesion, perilesional and NAWM volumes).
The mean DVR in NAWM of patients was greater than that of the healthy volunteer white matter for both radioligands. Uptake for individual WML in patients was heterogeneous, but the median WML DVR and NAWM DVR for individual patients were strongly correlated (ρ = 0.94,
= 4 × 10
). A higher proportion of lesions were inactive in patients with SPMS (35%) than RRMS (23%), but active lesions were found in all patients, including those on highly efficacious treatments.
TSPO radioligand uptake was increased in the brains of MS patients relative to healthy controls with 2 TSPO radiotracers. WML showed heterogeneous patterns of uptake. Active lesions were found in patients with both RRMS and SPMS. Their independent prognostic significance needs further investigation. |
doi_str_mv | 10.2967/jnumed.116.187161 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2967_jnumed_116_187161</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>28302760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1130-a77785daa9c045898e544bd194d6f903f69988a8a657adc18ea04c95c588bcad3</originalsourceid><addsrcrecordid>eNo1kN1OwzAMhSMEYmPwANygvEBH3DaJcwmDsUmbQPyIy8pLUujUdlWbXezt6VR2ZfkcH1v-GLsFMY2N0vfbel95NwVQU0ANCs7YGGQiI6mUPmdj0UuRlEKO2FXXbYUQChEv2SjGRMRaiTHLAPgsent8j5FT7Tggnx9b6PUnH7wN_Pu3CJ6vKQTf8mWdl1RVFHbtgS_6gXb342tfhAMvar7el6FoSs8_bNk7XdFds4ucys7f_NcJ-5o_f84W0er1ZTl7WEUWIBERaa1ROiJjRSrRoJdpunFgUqdyI5JcGYNISEpqchbQk0itkVYibiy5ZMJg2Gv7s13r86xpi4raQwYiO8LKBlj9vyobYPWZuyHT7DdH65Q40Un-ADSqZJ0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>11 C-PBR28 and 18 F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Datta, Gourab ; Colasanti, Alessandro ; Kalk, Nicola ; Owen, David ; Scott, Gregory ; Rabiner, Eugenii A ; Gunn, Roger N ; Lingford-Hughes, Anne ; Malik, Omar ; Ciccarelli, Olga ; Nicholas, Richard ; Nei, Lei ; Battaglini, Marco ; De Stefano, Nicola ; Matthews, Paul M</creator><creatorcontrib>Datta, Gourab ; Colasanti, Alessandro ; Kalk, Nicola ; Owen, David ; Scott, Gregory ; Rabiner, Eugenii A ; Gunn, Roger N ; Lingford-Hughes, Anne ; Malik, Omar ; Ciccarelli, Olga ; Nicholas, Richard ; Nei, Lei ; Battaglini, Marco ; De Stefano, Nicola ; Matthews, Paul M</creatorcontrib><description>The objective of this study was to assess microglial activation in lesions and in normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients using PET.
Thirty-four MS patients (7 with secondary progressive MS [SPMS], 27 with relapsing remitting MS [RRMS]) and 30 healthy volunteers, genetically stratified for translocator protein (TSPO) binding status, underwent PET scanning with TSPO radioligands (
C-PBR28 or
F-PBR111). Regional TSPO availability was measured as a distribution volume ratio (DVR) relative to the caudate (a pseudoreference region). White matter lesions (WMLs) were classified as "active" (DVR highest in the lesion), "peripherally active" (perilesional DVR highest), "inactive" (DVR highest in surrounding NAWM), or "undifferentiated" (similar DVR across lesion, perilesional and NAWM volumes).
The mean DVR in NAWM of patients was greater than that of the healthy volunteer white matter for both radioligands. Uptake for individual WML in patients was heterogeneous, but the median WML DVR and NAWM DVR for individual patients were strongly correlated (ρ = 0.94,
= 4 × 10
). A higher proportion of lesions were inactive in patients with SPMS (35%) than RRMS (23%), but active lesions were found in all patients, including those on highly efficacious treatments.
TSPO radioligand uptake was increased in the brains of MS patients relative to healthy controls with 2 TSPO radiotracers. WML showed heterogeneous patterns of uptake. Active lesions were found in patients with both RRMS and SPMS. Their independent prognostic significance needs further investigation.</description><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 1535-5667</identifier><identifier>EISSN: 2159-662X</identifier><identifier>DOI: 10.2967/jnumed.116.187161</identifier><identifier>PMID: 28302760</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Biological Transport ; Brain - diagnostic imaging ; Brain - metabolism ; Female ; Humans ; Inflammation - diagnostic imaging ; Ligands ; Male ; Middle Aged ; Multiple Sclerosis - diagnostic imaging ; Multiple Sclerosis - metabolism ; Positron-Emission Tomography ; Pyridines - metabolism ; Pyrimidines - metabolism ; White Matter - diagnostic imaging ; White Matter - metabolism</subject><ispartof>Journal of Nuclear Medicine, 2017-09, Vol.58 (9), p.1477-1482</ispartof><rights>2017 by the Society of Nuclear Medicine and Molecular Imaging.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1130-a77785daa9c045898e544bd194d6f903f69988a8a657adc18ea04c95c588bcad3</citedby><cites>FETCH-LOGICAL-c1130-a77785daa9c045898e544bd194d6f903f69988a8a657adc18ea04c95c588bcad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28302760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Datta, Gourab</creatorcontrib><creatorcontrib>Colasanti, Alessandro</creatorcontrib><creatorcontrib>Kalk, Nicola</creatorcontrib><creatorcontrib>Owen, David</creatorcontrib><creatorcontrib>Scott, Gregory</creatorcontrib><creatorcontrib>Rabiner, Eugenii A</creatorcontrib><creatorcontrib>Gunn, Roger N</creatorcontrib><creatorcontrib>Lingford-Hughes, Anne</creatorcontrib><creatorcontrib>Malik, Omar</creatorcontrib><creatorcontrib>Ciccarelli, Olga</creatorcontrib><creatorcontrib>Nicholas, Richard</creatorcontrib><creatorcontrib>Nei, Lei</creatorcontrib><creatorcontrib>Battaglini, Marco</creatorcontrib><creatorcontrib>De Stefano, Nicola</creatorcontrib><creatorcontrib>Matthews, Paul M</creatorcontrib><title>11 C-PBR28 and 18 F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis</title><title>Journal of Nuclear Medicine</title><addtitle>J Nucl Med</addtitle><description>The objective of this study was to assess microglial activation in lesions and in normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients using PET.
Thirty-four MS patients (7 with secondary progressive MS [SPMS], 27 with relapsing remitting MS [RRMS]) and 30 healthy volunteers, genetically stratified for translocator protein (TSPO) binding status, underwent PET scanning with TSPO radioligands (
C-PBR28 or
F-PBR111). Regional TSPO availability was measured as a distribution volume ratio (DVR) relative to the caudate (a pseudoreference region). White matter lesions (WMLs) were classified as "active" (DVR highest in the lesion), "peripherally active" (perilesional DVR highest), "inactive" (DVR highest in surrounding NAWM), or "undifferentiated" (similar DVR across lesion, perilesional and NAWM volumes).
The mean DVR in NAWM of patients was greater than that of the healthy volunteer white matter for both radioligands. Uptake for individual WML in patients was heterogeneous, but the median WML DVR and NAWM DVR for individual patients were strongly correlated (ρ = 0.94,
= 4 × 10
). A higher proportion of lesions were inactive in patients with SPMS (35%) than RRMS (23%), but active lesions were found in all patients, including those on highly efficacious treatments.
TSPO radioligand uptake was increased in the brains of MS patients relative to healthy controls with 2 TSPO radiotracers. WML showed heterogeneous patterns of uptake. Active lesions were found in patients with both RRMS and SPMS. Their independent prognostic significance needs further investigation.</description><subject>Adult</subject><subject>Biological Transport</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammation - diagnostic imaging</subject><subject>Ligands</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple Sclerosis - diagnostic imaging</subject><subject>Multiple Sclerosis - metabolism</subject><subject>Positron-Emission Tomography</subject><subject>Pyridines - metabolism</subject><subject>Pyrimidines - metabolism</subject><subject>White Matter - diagnostic imaging</subject><subject>White Matter - metabolism</subject><issn>0161-5505</issn><issn>1535-5667</issn><issn>2159-662X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kN1OwzAMhSMEYmPwANygvEBH3DaJcwmDsUmbQPyIy8pLUujUdlWbXezt6VR2ZfkcH1v-GLsFMY2N0vfbel95NwVQU0ANCs7YGGQiI6mUPmdj0UuRlEKO2FXXbYUQChEv2SjGRMRaiTHLAPgsent8j5FT7Tggnx9b6PUnH7wN_Pu3CJ6vKQTf8mWdl1RVFHbtgS_6gXb342tfhAMvar7el6FoSs8_bNk7XdFds4ucys7f_NcJ-5o_f84W0er1ZTl7WEUWIBERaa1ROiJjRSrRoJdpunFgUqdyI5JcGYNISEpqchbQk0itkVYibiy5ZMJg2Gv7s13r86xpi4raQwYiO8LKBlj9vyobYPWZuyHT7DdH65Q40Un-ADSqZJ0</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Datta, Gourab</creator><creator>Colasanti, Alessandro</creator><creator>Kalk, Nicola</creator><creator>Owen, David</creator><creator>Scott, Gregory</creator><creator>Rabiner, Eugenii A</creator><creator>Gunn, Roger N</creator><creator>Lingford-Hughes, Anne</creator><creator>Malik, Omar</creator><creator>Ciccarelli, Olga</creator><creator>Nicholas, Richard</creator><creator>Nei, Lei</creator><creator>Battaglini, Marco</creator><creator>De Stefano, Nicola</creator><creator>Matthews, Paul M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>11 C-PBR28 and 18 F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis</title><author>Datta, Gourab ; Colasanti, Alessandro ; Kalk, Nicola ; Owen, David ; Scott, Gregory ; Rabiner, Eugenii A ; Gunn, Roger N ; Lingford-Hughes, Anne ; Malik, Omar ; Ciccarelli, Olga ; Nicholas, Richard ; Nei, Lei ; Battaglini, Marco ; De Stefano, Nicola ; Matthews, Paul M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1130-a77785daa9c045898e544bd194d6f903f69988a8a657adc18ea04c95c588bcad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Biological Transport</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammation - diagnostic imaging</topic><topic>Ligands</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple Sclerosis - diagnostic imaging</topic><topic>Multiple Sclerosis - metabolism</topic><topic>Positron-Emission Tomography</topic><topic>Pyridines - metabolism</topic><topic>Pyrimidines - metabolism</topic><topic>White Matter - diagnostic imaging</topic><topic>White Matter - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Datta, Gourab</creatorcontrib><creatorcontrib>Colasanti, Alessandro</creatorcontrib><creatorcontrib>Kalk, Nicola</creatorcontrib><creatorcontrib>Owen, David</creatorcontrib><creatorcontrib>Scott, Gregory</creatorcontrib><creatorcontrib>Rabiner, Eugenii A</creatorcontrib><creatorcontrib>Gunn, Roger N</creatorcontrib><creatorcontrib>Lingford-Hughes, Anne</creatorcontrib><creatorcontrib>Malik, Omar</creatorcontrib><creatorcontrib>Ciccarelli, Olga</creatorcontrib><creatorcontrib>Nicholas, Richard</creatorcontrib><creatorcontrib>Nei, Lei</creatorcontrib><creatorcontrib>Battaglini, Marco</creatorcontrib><creatorcontrib>De Stefano, Nicola</creatorcontrib><creatorcontrib>Matthews, Paul M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of Nuclear Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Datta, Gourab</au><au>Colasanti, Alessandro</au><au>Kalk, Nicola</au><au>Owen, David</au><au>Scott, Gregory</au><au>Rabiner, Eugenii A</au><au>Gunn, Roger N</au><au>Lingford-Hughes, Anne</au><au>Malik, Omar</au><au>Ciccarelli, Olga</au><au>Nicholas, Richard</au><au>Nei, Lei</au><au>Battaglini, Marco</au><au>De Stefano, Nicola</au><au>Matthews, Paul M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>11 C-PBR28 and 18 F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis</atitle><jtitle>Journal of Nuclear Medicine</jtitle><addtitle>J Nucl Med</addtitle><date>2017-09</date><risdate>2017</risdate><volume>58</volume><issue>9</issue><spage>1477</spage><epage>1482</epage><pages>1477-1482</pages><issn>0161-5505</issn><eissn>1535-5667</eissn><eissn>2159-662X</eissn><abstract>The objective of this study was to assess microglial activation in lesions and in normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients using PET.
Thirty-four MS patients (7 with secondary progressive MS [SPMS], 27 with relapsing remitting MS [RRMS]) and 30 healthy volunteers, genetically stratified for translocator protein (TSPO) binding status, underwent PET scanning with TSPO radioligands (
C-PBR28 or
F-PBR111). Regional TSPO availability was measured as a distribution volume ratio (DVR) relative to the caudate (a pseudoreference region). White matter lesions (WMLs) were classified as "active" (DVR highest in the lesion), "peripherally active" (perilesional DVR highest), "inactive" (DVR highest in surrounding NAWM), or "undifferentiated" (similar DVR across lesion, perilesional and NAWM volumes).
The mean DVR in NAWM of patients was greater than that of the healthy volunteer white matter for both radioligands. Uptake for individual WML in patients was heterogeneous, but the median WML DVR and NAWM DVR for individual patients were strongly correlated (ρ = 0.94,
= 4 × 10
). A higher proportion of lesions were inactive in patients with SPMS (35%) than RRMS (23%), but active lesions were found in all patients, including those on highly efficacious treatments.
TSPO radioligand uptake was increased in the brains of MS patients relative to healthy controls with 2 TSPO radiotracers. WML showed heterogeneous patterns of uptake. Active lesions were found in patients with both RRMS and SPMS. Their independent prognostic significance needs further investigation.</abstract><cop>United States</cop><pmid>28302760</pmid><doi>10.2967/jnumed.116.187161</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-5505 |
ispartof | Journal of Nuclear Medicine, 2017-09, Vol.58 (9), p.1477-1482 |
issn | 0161-5505 1535-5667 2159-662X |
language | eng |
recordid | cdi_crossref_primary_10_2967_jnumed_116_187161 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adult Biological Transport Brain - diagnostic imaging Brain - metabolism Female Humans Inflammation - diagnostic imaging Ligands Male Middle Aged Multiple Sclerosis - diagnostic imaging Multiple Sclerosis - metabolism Positron-Emission Tomography Pyridines - metabolism Pyrimidines - metabolism White Matter - diagnostic imaging White Matter - metabolism |
title | 11 C-PBR28 and 18 F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A59%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=11%20C-PBR28%20and%2018%20F-PBR111%20Detect%20White%20Matter%20Inflammatory%20Heterogeneity%20in%20Multiple%20Sclerosis&rft.jtitle=Journal%20of%20Nuclear%20Medicine&rft.au=Datta,%20Gourab&rft.date=2017-09&rft.volume=58&rft.issue=9&rft.spage=1477&rft.epage=1482&rft.pages=1477-1482&rft.issn=0161-5505&rft.eissn=1535-5667&rft_id=info:doi/10.2967/jnumed.116.187161&rft_dat=%3Cpubmed_cross%3E28302760%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28302760&rfr_iscdi=true |